Canaccord Genuity Maintains Buy on Concentrix, Lowers Price Target to $55

Benzinga Newsdesk www.benzinga.com Negative 67.8%

Neg 67.8% Neu 0% Pos 0%

Canaccord Genuity analyst Luke Morison maintains Concentrix (NASDAQ:CNXC) with a Buy and lowers the price target from $80 to $55.